Integrative oncology: Addressing the global challenges of cancer prevention and treatment
JJ Mao, GG Pillai, CJ Andrade… - CA: A Cancer …, 2022 - Wiley Online Library
The increase in cancer incidence and mortality is challenging current cancer care delivery
globally, disproportionally affecting low‐and middle‐income countries (LMICs) when it …
globally, disproportionally affecting low‐and middle‐income countries (LMICs) when it …
Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis
Importance Research into acupuncture and acupressure and their application for cancer
pain has been growing, but the findings have been inconsistent. Objective To evaluate the …
pain has been growing, but the findings have been inconsistent. Objective To evaluate the …
Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho‐oncologic relevance
KS Yeung, M Hernandez, JJ Mao… - Phytotherapy …, 2018 - Wiley Online Library
Anxiety and depression are prevalent among cancer patients, with significant negative
impact. Many patients prefer herbs for symptom relief to conventional medications which …
impact. Many patients prefer herbs for symptom relief to conventional medications which …
Integrative medicine for pain management in oncology: society for integrative oncology–ASCO guideline
JJ Mao, N Ismaila, T Bao, D Barton… - Journal of Clinical …, 2022 - ingentaconnect.com
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other health care providers on integrative approaches to …
practicing physicians and other health care providers on integrative approaches to …
[HTML][HTML] Psychological outcomes and health beliefs in adolescent and young adult survivors of childhood cancer and controls
Purpose The purpose of this study was to compare adolescent and young adult (AYA)
pediatric cancer survivors and peers without a history of serious illness on psychological …
pediatric cancer survivors and peers without a history of serious illness on psychological …
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
T Bao, C Basal, C Seluzicki, SQ Li, AD Seidman… - Breast cancer research …, 2016 - Springer
Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity associated with
chemotherapy, but researchers rarely study its risk factors, fall risk, and prevalence in long …
chemotherapy, but researchers rarely study its risk factors, fall risk, and prevalence in long …
A comprehensive definition for integrative oncology
CM Witt, LG Balneaves, MJ Cardoso… - Journal of the …, 2017 - academic.oup.com
Background Integrative oncology, which is generally understood to refer to the use of a
combination of complementary medicine therapies in conjunction with conventional cancer …
combination of complementary medicine therapies in conjunction with conventional cancer …
Symptom burden among cancer survivors: impact of age and comorbidity
Background: Previous research among specific cancer populations has shown high but
variable symptom burden; however, very little is known about its extent and pattern among …
variable symptom burden; however, very little is known about its extent and pattern among …
Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors
BACKGROUND: Arthralgia is common in postmenopausal breast cancer survivors (BCS)
who are receiving aromatase inhibitors (AIs). The objective of this study was to evaluate the …
who are receiving aromatase inhibitors (AIs). The objective of this study was to evaluate the …
Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients
Purpose Most of the 182,460 women diagnosed with breast cancer in the United States this
year will become long-term survivors. Helping these women transition from active treatment …
year will become long-term survivors. Helping these women transition from active treatment …